Record attendance at BIO-Europe
Düsseldorf – BIO-Europe 2011 in Düsseldorf has again broken all previous records in terms of participants and company numbers. More than 3,000 representatives from 1,800 companies registered for Europe‘s largest partnering event. Svenja Schulze, the Innovation Minister of Germany’s federal state North Rhine-Westphalia (NRW) opened the meeting on October 31 at the fairgrounds in Düsseldorf. „BIO-Europe creates new opportunities – for the participating companies and therefore for the cluster in NRW,“ said the politician. Biotechnology can provide solutions for tomorrow’s problems: „Biotechnology is important per se“, said Schulze. Bernward Garthoff, manager of the NRW biotech cluster BIO.NRW, added: „BIO-Europe is a landmark event on the calendars of business development executives from North Rhine- Westphalia. It is a perfect platform to raise our international profile and forge stronger links with the innovators from around the world.“
The main purpose of the event is to create new partnerships. Participants can schedule meetings online in advance of the conference, while on the spot, deals are negotiated in over 1,000 partnering booths. This year, more than 15,000 meetings were held during the three day conference. In addition to the partnering opportunities, BIO- Europe offered a vast number of discussion panels and forums at the fair, where experienced industry representatives analyse the latest trends. This included this year, again the field of personalised medicine: Even ten years after the completion of the Human Genome Project–it seems to remain at an early stage. In the eyes of Peer Schatz, CEO of Qiagen, personalised medicine, however, involves more than just the development of tailor-made drugs: “Data management is key“ said Schatz. “More information leads to better decisions and a better outcome”, he added. In the future, the results of different diagnostic methods, such as molecular biology or imaging techniques will be combined with personal sequence data. „The modern doctor will have to manage complex mathematical algorithms,“ said Schatz.